Market Research Blog

[300 Pages Report] The global catheter-directed thrombolysis market is expected to be worth US$ 432.0 million in 2022, rising at a 5.9% CAGR to be worth US$ 814.0 million by 2032.

Catheter-directed Thrombolysis Infection Market: Drivers and Restraints

The primary factor driving the growth of catheter-directed thrombolysis market is increasing the prevalence of stroke, pulmonary embolism and deep vein thrombosis around the globe. Besides that, the rising incidences of obesity along increasing geriatric population will propel the growth of catheter-directed thrombolysis market. Moreover, the availability of emergency medical services and favourable health insurance coverage will also upsurge the growth of catheter-directed thrombolysis market. The scarcity of high health infrastructure in low economic countries will restrain the growth of catheter-directed thrombolysis market over the forecast period. Furthermore, a minor risk associated with the catheter-directed thrombolysis procedure will also restrain the growth of this market to some extent.

To remain ahead of your competitors, request for a sample – https://www.futuremarketinsights.com/reports/sample/rep-gb-5143

Thrombolysis is the therapeutic therapy to treat the clots in blot vessel and improve the blood flow to prevent the damage of tissue and organs. Thrombolysis can be done by injection of clot-busting drugs through an intravenous (IV) line or through a catheter which delivers the drugs directly to the blocking sites. Catheter-directed thrombolysis is a minimal invasive treatment which resolves the issue of clotted blood in the blood vessel. When the blood in the body has improper flow, it gets started to coagulate, which results the formation of semi-solid gel or clouting of blood. The blood clot may continue to grow within the blood vessel and blocks the blood flow within that blood vessel, this may cause the damage of tissue or organ.  The equipment of catheter-directed thrombolysis includes an x-ray camera, catheter, special medications and a medical device is used to dissolve the blood clots.  Along with x-ray camera and catheter, this equipment consists of a radiographic table, one or two x-ray tubes and a monitor to visualize the procedure. The x-ray imaging is used for guiding the medication to the site of the blood clot. X-ray machine produces the video of entire procedure which may visualize on a monitor. A catheter used during the thrombolysis, long, thin and hollow plastic tube. These catheters are designed in such way that medication can be easily delivered to the blood clotted site. Some other devices are also used with equipment during the procedure, such as ultrasound machine and other devices to monitor the heartbeat and blood pressure.

Catheter-directed Thrombolysis Market: Key Players 

Examples of some of the market participants in Catheter-directed Thrombolysis market identified across the value chain include Angio Dynamics, Inc., Boston Scientific Corporation, iVascular SLU, Straub Medical AG and others.

The research report presents a comprehensive assessment of the market and contains thoughtful insights, facts, historical data, and statistically supported and industry-validated market data. It also contains projections using a suitable set of assumptions and methodologies. The research report provides analysis and information according to market segments such as geographies, application, and industry.

Ask from Market Research Expert – https://www.futuremarketinsights.com/ask-question/rep-gb-5143

The report covers exhaustive analysis on:

• Market Segments
• Market Dynamics
• Market Size
• Current Trends/Issues/Challenges
• Competition & Companies involved
• Value Chain

The regional analysis includes:

• North America (U.S., Canada)
• Latin America (Mexico. Brazil)
• Western Europe (Germany, Italy, France, U.K, Spain, Nordic countries, Belgium, Netherlands, Luxembourg)
• Eastern Europe (Poland, Russia)
• Asia-Pacific (China, India, ASEAN, Australia & New Zealand)
• Japan
• The Middle East and Africa (GCC, S. Africa, N. Africa)

The report is a compilation of first-hand information, qualitative and quantitative assessment by industry analysts, inputs from industry experts and industry participants across the value chain. The report provides in-depth analysis of parent market trends, macroeconomic indicators and governing factors along with market attractiveness as per segments. The report also maps the qualitative impact of various market factors on market segments and geographies.

For in-depth insights, Download a PDF Brochure – https://www.futuremarketinsights.com/reports/brochure/rep-gb-5143

Catheter-directed Thrombolysis Market: Segmentation

The global Catheter-directed Thrombolysis market is classified on the basis of delivery mode, indication, end user and geographic region.

[345 Pages Report] As per Future Market Insights’ latest industry analysis, the global cholesterol API market was valued at around US$ 258.4 Mn in 2021 and is projected to exhibit a CAGR of 4.7% over the forecast period (2022-2032). The global market is estimated to be valued at US$ 426.9 Mn in 2032.

Liposomes are a very important part of any drug delivery system with many beneficial properties such as easy preparation, bilayer structure assembling the cellular membrane, and high biocompatibility. Extensive efforts have been dedicated to the use of cholesterol in liposome-based formulations.

Cholesterol, being an integral part of any biological membrane, plays a significant role in liposomal formulations. Liposomes with higher cholesterol content are highly stable.

According to a study by Ascension Sciences published in December 2020, parameters like stability, size, and encapsulation efficiency are used during liposome formulation. Stability of a liposome formulation is greatly influenced by the amount of cholesterol present. A higher percentage of cholesterol favors the development of larger liposomes with less encapsulation effectiveness and higher drug retention.

Request Sample @ https://www.futuremarketinsights.com/reports/sample/rep-gb-15406

Despite various applications of liposomes, including diagnosis, food products, gene delivery, drug & vaccine delivery, and biosensor manufacturing, their use is severely constrained by their physicochemical instability. Cholesterol plays a crucial role in the stability of a liposomal membrane.

Moreover, cholesterol affects fluidity, drug retention, phospholipid packing, transition temperature (Tm), permeability, elasticity, membrane strength, and plasma stability. Researchers are set to use cholesterol as a promising substance for the stability of liposomes.

Owing to the aforementioned factors, the global cholesterol API market is set to gain traction over the forecast period.

Key Takeaways: Cholesterol API Market

• By source, the animal-derived segment held approximately 7% of the cholesterol API market share in 2021 owing to their easy availability and low cost.
• By manufacturing process, the GMP segment is set to generate a market share of around 9% by 2032.
• By end user, the monoclonal antibodies segment is projected to grow at a CAGR of 0% during the forecast period.
• East Asia cholesterol API market is expected to showcase the highest CAGR of 6% among all other regions from 2022 to 2032.
• The U.S. cholesterol API market is anticipated to exhibit growth at a lucrative CAGR of 6% during the forecast period.

“Rising demand for RNA vaccines and monoclonal antibodies is projected to drive growth in the next decade. Besides, increasing use of liposomal formulations in drug delivery systems is set to propel sales of cholesterol APIs across the globe,” says an analyst of Future Market Insights.

Ask An Analyst @ https://www.futuremarketinsights.com/ask-the-analyst/rep-gb-15406

Competitive Landscape: Cholesterol API Market

The cholesterol API market is highly fragmented and it includes a variety of regional, start-up, and established companies. In order to increase their market share, key players are signing a large number of agreements and engaging in mergers & acquisitions, as well as collaborations.

For instance,

• In May 2021, CordenPharma and the Otto-von-Guericke-University of Magdeburg, Germany developed a scalable synthesis of pharma-grade cholesterol which is used as part of the lipid cocktail for the assembly of effective mRNA-based vaccines.
• In May 2020, Evonik announced €25m first stage of a new long-term program to support the high demand for contract manufacturing of APIs and advanced intermediates across Europe.

Get More Insights on Cholesterol API Market

Future Market Insights offers a unique perspective and actionable insights on the cholesterol API market in its latest study, presenting a historical demand assessment of 2017 – 2021 and projections for 2022 – 2032.

The research study is based on the source (animal-derived, plant-derived, and synthetic), manufacturing process (GMP and non-GMP), and end user (RNA vaccines, monoclonal antibodies, and others) across seven key regions of the world.

Buy Now/Purchase @ https://www.futuremarketinsights.com/checkout/15406

Cholesterol API Market Outlook by Category

By Source:

• Animal Derived
• Plant Derived
• Synthetic

By Manufacturing Process:

• GMP
• Non – GMP

By End User:

• RNA Vaccines
• Monoclonal Antibodies
• Others

[314 Pages Report] According to a recent study by Future Market Insights (FMI), the global dry eye syndrome market is expected to witness high growth during the forecast period. The market is expected to grow from US$ 4.52 Bn in 2021 to around US$ 8.84 Bn by 2031. This reflects a cumulative CAGR of around 7.0% over the forecast period (2022-2031).

Dry eye syndrome is a lifestyle diseases caused by long-term exposure to computer screen, resulting in reporting of the higher incidence rates across the developing economies. Also, this factor has pushed various ophthalmology care providers to educate and create awareness about the syndrome.

One such example is the Narayana Nethralaya, a super specialty eye hospital based out of India, a dedicated lab to diagnose and treat dry eyes. This lab aims to provide patients with awareness about eye lid problems such as Meibomian gland dysfunction, which lead to the development of dry eye syndrome.

Also, similar trend is observed in developed market such as U.S. Various government awareness campaigns and not for profit initiatives try to create awareness about the dry eye disease to the population that does not have access to eye care facilities. Eye Care America is an example of a public service organization run by the American Academy of Ophthalmology Foundation that provides free eye care through volunteer ophthalmologists.

To remain ahead of your competitors, request for a sample – https://www.futuremarketinsights.com/reports/sample/rep-gb-1215

Further, those who are age 65 or older and who have not seen an ophthalmologists in three or more years may be eligible to receive a comprehensive, medical eye exam and up to one year of care at no out-of-pocket cost. This consequently will increase the utilization of dry eye treatment products and drive the growth of the dry eye syndrome treatment market during the forecast period. .

Market Outlook:

Key Takeaways from Dry Eye Syndrome Treatment Study

• Greater acceptance of artificial tears owing to improved patient comfort leads the artificial tears segment to account for the maximum share of 60.8% in 2021, expanding at 7.1% CAGR during the forecast period.
• By prescription, Rx prescriptions are projected to account for 71.3% of the market share in 2022 indicating highest demand, since majority of population visit hospitals to get the checkup done, in turn increasing the numbers of Rx prescriptions.
• Retail pharmacies, as distribution channel held the largest share of 60.8% in 2021 and is expected to grow with the same trend throughout the forecast period.
• By region, North America held the largest share of 37.6% of the dry eye syndrome treatment market in 2021 indicating the growth due to high prevalence and high treatment adoption rate in North America.

Get a Tailored Made Report to Match Your requirements, Ask from Market Research Expert – https://www.futuremarketinsights.com/ask-question/rep-gb-1215

“Growing incidence of dry eye syndrome due to growing aging population, and long working hours (increase in screen time) to drive the demand of Dry Eye Syndrome treatment products over the Decade,” says the FMI Analyst

Who is winning?

Key Players :

• Allergen plc. (Abbvie)
• Novartis AG
• Otsuka Pharmaceuticals Co.Ltd.
• Bausch Health Companies Inc.
• Akron Inc.
• Johnson & Johnson Inc.
• Thea Pharmaceuticals Limited
• OASIS Medical
• Altaire Pharmaceuticals Inc.
• Boiron USA
• Similasan Corporation
• Scope Ophthalmics Ltd.
• Reckitt Benckiser Group PLC
• Medicom Healthcare Ltd
• FDC Limited.
• Lupin Limited
• Jamjoom Pharmaceuticals Co.
• Sentiss Pharma Private limited.

Some of the leading manufacturers of dry-eye-syndrome treatment market focuses on the product launch and approvals with global expansion objectives, thereby, enhancing their market presence.

• In January 2021, SIFI an Italy based international ophthalmic company launched SYNFO for moisturizing and lubrication in dry eye treatment.
• In December 2020, Alcon Canada announced the launch of its new product Systane an ultra-hydration lubricant eye drops preservative free containing Hyaluronic acid and HP-guar
• In November 2020, Santen Pharmaceutical launched Cationorm categorized as artificial tear for moisturisation and long lasting relief to dry eye.

Want more insights?

Future Market Insights brings the comprehensive research report on forecasted revenue growth at global, regional, and country levels and provides an analysis of the latest industry trends in each of the sub-segments from 2016 to 2031. The global dry eye syndrome treatment market is segmented in detail to cover every aspect of the market and present a complete market intelligence approach to the reader.

The study provides compelling insights on dry eye syndrome treatment segment based on Product (Cyclosporine, Topical Corticosteroids, and Artificial Tears Punctal Plugs (removable, dissolvable), oral omega supplements, and others), prescription (Rx, OTC, Medical Device), distribution channel (Hospital Pharmacies, Eye Health Clinics, Retail Pharmacies, and Online Pharmacies) across seven major regions.

About FMI:

Future Market Insights (ESOMAR certified market research organization and a member of Greater New York Chamber of Commerce) provides in-depth insights into governing factors elevating the demand in the market. It discloses opportunities that will favor the market growth in various segments on the basis of Source, Application, Sales Channel and End Use over the next 10-years.

Contact Us:
Future Market Insights,
Unit No: 1602-006,
Jumeirah Bay 2,
Plot No: JLT-PH2-X2A,
Jumeirah Lakes Towers,
Dubai,
United Arab Emirates
For Sales Enquiries: sales@futuremarketinsights.com
Website: https://www.futuremarketinsights.com
LinkedIn| Twitter| Blogs

[206 Pages Report] Increasing adoption of dosimeters at various healthcare centers would push the global dosimetry market revenues beyond a value of US$ 4 Bn by 2029, as projected by a new Future Market Insights (FMI) report.

Strict government regulations regarding radiation toxicity levels, growing awareness about the harmful effect of radiation, and rising concerns about the health of employees working in environments with radiation exposure have prompted the use of dosimetry.

Rising adoption of radiopharmaceuticals used for diagnostic purposes can increase the radiation levels in hospitals. This has, in turn, increased the risk of radiation-related diseases among healthcare professionals. There has been a rise in the adoption of wearable dosimeters by hospitals to analyse radiation levels among their staff, which has created opportunity for the growth of the dosimetry market.

To remain ahead of your competitors, request for a sample – https://www.futuremarketinsights.com/reports/sample/rep-gb-3482

“Rise in the install base of internal radiation therapy machines in the past decade has necessitated the need for active dosimeters for real-time monitoring of radiation exposure of hospital staff”, says an FMI analyst.

Key Takeaways from Dosimetry Market Study

The adoption of personal electronic dosimeters for real-time monitoring is expected to gain traction, and contribute more than 60% of revenue share during the forecast period.
Growing adoption of wearable dosimeters by hospital professionals to analyse radiation levels is expected to contribute to the significant revenue share of the segment.
Passive dosimeters dominate the market by energy, as these are relatively cheaper than active dosimeters.
In terms of end user, industrial and medical are expected to collectively gain more than 40% of market share during the forecast period.
North America is the leading market, while the dosimetry market in South Asia is expected to grow at significant rate, owing to increasing healthcare infrastructure and industrialization.

Ask from Market Research Expert – https://www.futuremarketinsights.com/ask-question/rep-gb-3482

Acquisition Key Strategy Followed by Leading Manufacturers

Leading manufacturers in the dosimetry market are focusing on the acquisition strategy to enhance their product portfolio and expand their regional presence.  For instance, in 2017, Fortive acquired Landauer, a leading global provider of subscription-based technical and analytical services to determine occupational and environmental radiation exposure.

In 2016, Mirion Technologies Inc. acquired Canberra Industries. Mirion’s acquisition of Canberra brings together two of the most respected and experienced industry players, and offers comprehensive and compelling solutions for the global customer base.

Want more insights on the dosimetry market?

A new study by Future Market Insights opines on the evolution of the dosimetry market from 2014-2021, and presents demand projections for 2022-2029, on the basis of product (personal electronic dosimeters, self-reading dosimeters, processed dosimeters), modality (wearable and non-wearable), energy (active dosimeters and passive dosimeters), and end user (industrial, medical, oil and gas, defence, homeland security, mining, environmental, others), across seven prominent regions.

For in-depth competitive analysis, Buy Now – https://www.futuremarketinsights.com/checkout/3482

Dosimetry Market by Category

By Product Type :

Personal Electronic Dosimeter
Self-reading Dosimeters
Processed Dosimeters

By Modality :

Wearable
Collar level
Chest level
Waist level
Wrist level
Finger level
Non-wearable

By Energy :

Active Dosimeters
Passive Dosimeters
Optically Stimulated Luminescence Dosimeter (OSLD)
Thermoluminescence Dosimeters (TLD)
Radiophotoluminescence (RPL)

By End User :

Industrial
Medical
Oil and Gas
Defense, Homeland Security
Mining
Environmental
Others

By Region :

North America
Latin America
Europe
South Asia
East Asia
Oceania
Middle-East & Africa

About FMI:

[193 Pages Report] Immunization and vaccination are accepted as the most cost-effective and viable method of controlling infectious veterinary diseases. Veterinary vaccines play an important role in the reduction of diseases, in both, livestock and companion animals.

Increasing awareness regarding animal health and growing demand for animal protein food products are key factors expected to augur well for the veterinary vaccines market. Veterinary vaccines are witnessing demand upsurge, globally, owing to increasing government-backed initiatives for the prevention of zoonotic diseases.

The global veterinary vaccines market is projected to be valued at US$ 9.1 Bn in 2022, and is expected to witness a CAGR of nearly 7% during the forecast period (2022–2026).

However, the coronavirus (COVID-19) pandemic has exposed the market to several uncertainties. With initial speculations blaming meat products for the transmission, the veterinary vaccines market witnessed a slowdown. That being said, further investigations have revealed that, meat consumption is not responsible for the COVID-19 contagion. As such, the veterinary vaccines market is gradually coming back on track, backed by increasing demand for animal-based products such as eggs, milk, and meat.

“Development of new and effective veterinary vaccines such as recombinant vaccines for infectious, parasitic, and metabolic diseases, and increasing animal disease eradication programs, will boost the growth of the veterinary vaccines market over the coming years.”

Key Takeaways of Veterinary Vaccines Market Study

• Attenuated live vaccines emerged as the largest segment by product, representing around 24% revenue share in veterinary vaccines market in 2021. Attenuated live vaccines are effective and are widely preferred for the treatment of animal diseases; they are expected to exhibit significant growth over the forecast period.
• By disease, the foot & mouth disease accounted for the highest revenue in 2021. High prevalence of foot & mouth disease is anticipated to drive demand for veterinary vaccines, worldwide.
• Veterinary clinics hold over 2/5 share of the veterinary vaccines market value, owing to increasing number of veterinary clinics.
• Based on species, livestock animals account for a leading revenue share in the veterinary vaccines market, owing to higher demand for livestock vaccines for better quality of meat and processed meat export.
• Cumulatively, North America and Western Europe contribute over 58% share in the global veterinary vaccines market, with North America leading the pack in terms of revenue share.

To remain ahead of your competitors, request for a sample – https://www.futuremarketinsights.com/reports/sample/rep-gb-409

Acquisition a Prominent Strategy Adopted by Veterinary Vaccine Manufacturers

The acquisition strategy helps in complementing the vaccine portfolio that adds significant value to an organization. For instance, in June 2016, Boehringer Ingelheim International GmbH signed an agreement with Sanofi’s animal-health business (Merial). In July 2018, Zoetis acquired Nexvet Biopharma. This collaboration strengthened the development platform of mAb therapies and added new alternatives to treat osteoarthritis in companion animals.

Want more insights?

Future Market Insights brings a comprehensive research report on forecasted revenue growth at global, regional, and country levels, and provides an analysis of the latest industry trends in each of the sub-segments from 2014 to 2026. The global veterinary vaccines market is segmented in detail to cover every aspect of the market and present a complete market intelligence approach to the reader.

The study provides compelling insights on the veterinary vaccines market on the basis of product (attenuated live vaccines, conjugate vaccines, inactivated vaccines, subunit vaccines, toxoid vaccines, DNA vaccines, and recombinant vaccines), disease (anaplasmosis, canine parvovirus, foot & mouth disease, new castle disease, distemper disease, influenza, porcine reproductive & respiratory syndrome (PRRS), and others), distribution channel (veterinary clinics, veterinary hospitals, veterinary research institutes, and retail pharmacies), and species (companion animals, companion animals, and equine), across seven major regions.

Key Segments of Veterinary Vaccines Industry Survey

By Product:

• Attenuated Live Vaccines
• Conjugate Vaccines
• Inactivated Vaccines
• Subunit Vaccines
• Toxoid Vaccines
• DNA Vaccines
• Recombinant Vaccines

By Disease:

• Anaplasmosis
• Canine Parvovirus
• Foot & Mouth Disease
• New Castle Disease
• Distemper Disease
• Influenza
• Porcine Reproductive & Respiratory Syndrome (PRRS)
• Others

By Distribution Channel:

• Veterinary Clinics
• Veterinary Hospitals
• Veterinary Research Institutes
• Retail Pharmacies

Get a Tailored Made Report to Match Your requirements, Ask from Market Research Expert – https://www.futuremarketinsights.com/ask-question/rep-gb-409

By Species:

• Companion Animals
  • Canine
  • Avian
  • Feline
• Livestock Animals
  • Aquatic
  • Bovine
  • Porcine
  • Ovine/Caprine
  • Poultry
• Equine

By Region:

• North America Veterinary Vaccines Market
• Latin America Veterinary Vaccines Market
• Europe Veterinary Vaccines Market
• East Asia Veterinary Vaccines Market
• South Asia & Pacific Veterinary Vaccines Market
• Middle East & Africa (MEA) Veterinary Vaccines Market

About FMI:

Future Market Insights (ESOMAR certified market research organization and a member of Greater New York Chamber of Commerce) provides in-depth insights into governing factors elevating the demand in the market. It discloses opportunities that will favor the market growth in various segments on the basis of Source, Application, Sales Channel and End Use over the next 10-years.

Contact Us:
Future Market Insights,
Unit No: 1602-006,
Jumeirah Bay 2,
Plot No: JLT-PH2-X2A,
Jumeirah Lakes Towers,
Dubai,
United Arab Emirates
For Sales Enquiries: sales@futuremarketinsights.com
Website: https://www.futuremarketinsights.com
LinkedIn| Twitter| Blogs

The global surface plasmon resonance market is estimated to be valued at US$ 910.4 Mn in 2022 and is expected to reach US$ 1.5 Bn by 2029, finds Future Market Insights (FMI) in a recent market survey.

Increasing adoption of label-free detection techniques over labelled detection techniques is due to their cost-effective nature. Additionally, the availability of versatile products coupled with surface plasmon resonance to enhance the specificity of tests is an important factor that will bolster the demand for surface plasmon resonance. Imaging systems help in increasing throughput at a remarkable speed and with precise motion and consistency in report generation. Furthermore, the introduction of multifunctional products for improved outcomes is also expected to drive the growth of the surface plasmon resonance market over the forecast period.